Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,197 | 40,574 | 30,776 | 24,004 | 47,320 |
| Marketable Securities | 125,287 | 106,154 | 116,137 | 110,714 | N/A |
| Receivables | 2,614 | 2,664 | 1,352 | 1,835 | 104,849 |
| TOTAL | $158,800 | $152,854 | $151,139 | $141,136 | $157,791 |
| Non-Current Assets | |||||
| PPE Net | 5,370 | 4,853 | 5,070 | 5,241 | 5,493 |
| Investments And Advances | 11,057 | 31,790 | 37,363 | 55,436 | 50,450 |
| Other Non-Current Assets | 1,596 | 1,727 | 1,847 | 1,988 | 2,102 |
| TOTAL | $18,023 | $38,370 | $44,280 | $62,665 | $58,045 |
| Total Assets | $176,823 | $191,224 | $195,419 | $203,801 | $215,836 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,805 | 9,653 | 16,029 | 12,268 | 12,474 |
| TOTAL | $24,529 | $25,154 | $32,857 | $27,506 | $29,824 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 15,327 | 15,055 | 16,456 | 14,878 | 16,973 |
| Other Non-Current Liabilities | 17,601 | 18,859 | 19,711 | 20,193 | 22,028 |
| TOTAL | $17,601 | $22,155 | $25,710 | $30,778 | $32,870 |
| Total Liabilities | $42,130 | $47,309 | $58,567 | $58,284 | $62,694 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 167,557 | 166,134 | 162,571 | 156,467 | 149,951 |
| Common Shares | 1,344,195 | 1,339,453 | 1,318,737 | 1,307,654 | 1,298,409 |
| Retained earnings | -1,237,236 | -1,220,142 | -1,203,803 | -1,181,871 | -1,164,304 |
| Other shareholders' equity | -49,468 | -49,634 | -50,488 | -51,004 | -50,097 |
| TOTAL | $134,693 | $143,915 | $136,852 | $145,517 | $153,142 |
| Total Liabilities And Equity | $176,823 | $191,224 | $195,419 | $203,801 | $215,836 |